Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model

다국어 초록 (Multilingual Abstract)

Diabetic foot ulcers (DFU) increase the risks of infection and amputation in patients with diabetes mellitus (DM). The impaired function and senescence of endothelial progenitor cells (EPCs) and high glucose-induced ROS likely exacerbate DFUs. We assessed EPCs in 60 patients with DM in a hospital or primary care setting. We also evaluated the therapeutic effects of exosomes secreted from adipose-derived stem cells (ADSCs) on stress-mediated senescence of EPCs induced by high glucose. Additionally, the effects of exosomes and Nrf2 overexpression in ADSCs were investigated in vitro and in vivo in a diabetic rat model. We found that ADSCs that secreted exosomes promoted proliferation and angiopoiesis in EPCs in a high glucose environment and that overexpression of Nrf2 increased this protective effect. Wounds in the feet of diabetic rats had a significantly reduced ulcerated area when treated with exosomes from ADSCs overexpressing Nrf2. Increased granulation tissue formation, angiogenesis, and levels of growth factor expression as well as reduced levels of inflammation and oxidative stress-related proteins were detected in wound beds. Our data suggest that exosomes from ADSCs can potentially promote wound healing, particularly when overexpressing Nrf2 and therefore that the transplantation of exosomes may be suitable for clinical application in the treatment of DFUs.

참고문헌 (Reference)

1 M E Edmonds, "‘Dermagraft’: a new treatment for diabetic foot ulcers" Wiley 14 (14): 1010-1011, 1997

2 Brem, H., "Wound-healing protocols for diabetic foot and pressure ulcers" 11 : 85-92, 2003

3 Michelle Massee, "Type I and II Diabetic Adipose-Derived Stem Cells Respond In Vitro to Dehydrated Human Amnion/Chorion Membrane Allograft Treatment by Increasing Proliferation, Migration, and Altering Cytokine Secretion" Mary Ann Liebert Inc 5 (5): 43-54, 2016

4 Manish Suthar, "Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series" Springer Nature 24 (24): 2017

5 Hongting Zheng, "Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy" American Diabetes Association 60 (60): 3055-3066, 2011

6 Marta García-Contreras, "Therapeutic Potential of Human Adipose-Derived Stem Cells (ADSCs) from Cancer Patients: A Pilot Study" Public Library of Science (PLoS) 9 (9): e113288-, 2014

7 Andrew JM Boulton, "The global burden of diabetic foot disease" Elsevier BV 366 (366): 1719-1724, 2005

8 Keng Wu, "The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway" American Physiological Society 310 (310): E828-E837, 2016

9 T. Jiang, "The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy" American Diabetes Association 59 (59): 850-860, 2010

10 Truyen Nguyen, "The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress" American Society for Biochemistry & Molecular Biology (ASBMB) 284 (284): 13291-13295, 2009

11 K. Trieb, "The Charcot foot" British Editorial Society of Bone & Joint Surgery 98-B (98-B): 1155-1159, 2016

12 Hiroyuki Yamauchi, "Senescence marker protein-30 deficiency impairs angiogenesis under ischemia" Elsevier BV 94 : 66-73, 2016

13 Peethambaran Arun, "Senescence Marker Protein 30 (SMP30) Expression in Eukaryotic Cells: Existence of Multiple Species and Membrane Localization" Public Library of Science (PLoS) 6 (6): e16545-, 2011

14 Kai Ma, "Nuclear accumulation of Yes-Associated Protein (YAP) maintains the survival of doxorubicin-induced senescent cells by promoting survivin expression" Elsevier BV 375 (375): 84-91, 2016

15 Jiwon Jang, "Nrf2, a Regulator of the Proteasome, Controls Self-Renewal and Pluripotency in Human Embryonic Stem Cells" Wiley 32 (32): 2616-2625, 2014

16 Y. Yuan, "Mesenchymal stem cell-conditioned media ameliorate diabetic endothelial dysfunction by improving mitochondrial bioenergetics via the Sirt1/AMPK/PGC-1  pathway" Portland Press Ltd. 130 (130): 2181-2198, 2016

17 Rongfeng Shi, "Localization of human adipose-derived stem cells and their effect in repair of diabetic foot ulcers in rats" Springer Nature 7 (7): 2016

18 Irene Zubiri, "Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes" Elsevier BV 166 (166): 474-484.e4, 2015

19 S. D. Ramsey, "Incidence, outcomes, and cost of foot ulcers in patients with diabetes" American Diabetes Association 22 (22): 382-387, 1999

20 Ling Zhou, "High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway" Springer Nature 13 (13): 2015

21 Xiaohong Xu, "Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China" Wiley 20 (20): 2078-2088, 2016

22 Shang-Chun Guo, "Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model" Ivyspring International Publisher 7 (7): 81-96, 2017

23 Li Hu, "Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts" Springer Nature 6 (6): 2016

24 Lin Zhao, "Exosomes Derived from Human Pulmonary Artery Endothelial Cells Shift the Balance between Proliferation and Apoptosis of Smooth Muscle Cells" S. Karger AG 137 (137): 43-53, 2017

25 Jieyuan Zhang, "Exosomes Derived from Human Endothelial Progenitor Cells Accelerate Cutaneous Wound Healing by Promoting Angiogenesis Through Erk1/2 Signaling" Ivyspring International Publisher 12 (12): 1472-1487, 2016

26 Kolluru, G. K., "Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing" 2012 : 918267-, 2012

27 Yossi Issan, "Endothelial Progenitor Cell Function Inversely Correlates With Long-term Glucose Control in Diabetic Patients: Association With the Attenuation of the Heme Oxygenase-Adiponectin Axis" Elsevier BV 28 (28): 728-736, 2012

28 Yossi Issan, "Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia" Elsevier BV 100-101 : 15-21, 2013

29 Shu Meng, "Downregulation of MicroRNA-130a Contributes to Endothelial Progenitor Cell Dysfunction in Diabetic Patients via Its Target Runx3" Public Library of Science (PLoS) 8 (8): e68611-, 2013

30 Bowering, C. K., "Diabetic foot ulcers. Pathophysiology, assessment, and therapy" 47 : 1007-1016, 2001

31 George Han, "Chronic Wound Healing: A Review of Current Management and Treatments" Springer Nature 34 (34): 599-610, 2017

32 Karakkattu Vijayan Kavitha, "Choice of wound care in diabetic foot ulcer: A practical approach" Baishideng Publishing Group Inc. 5 (5): 546-, 2014

33 Shi-Cong Tao, "Chitosan Wound Dressings Incorporating Exosomes Derived from MicroRNA-126-Overexpressing Synovium Mesenchymal Stem Cells Provide Sustained Release of Exosomes and Heal Full-Thickness Skin Defects in a Diabetic Rat Model" Wiley 6 (6): 736-747, 2017

34 Thomas W. Kensler, "Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway" Annual Reviews 47 (47): 89-116, 2007

35 Fu, C, "Bradykinin inhibits oxidative stress-induced senescence of endothelial progenitor cells through the B2R/AKT/RB and B2R/EGFR/RB signal pathways" 6 : 24675-24689, 2015

36 Duck Jin Hwang, "Association between diabetic foot ulcer and diabetic retinopathy" Public Library of Science (PLoS) 12 (12): e0175270-, 2017

37 Fetterolf, D. E., "An evaluation of healing metrics associated with commonly used advanced wound care products for the treatment of chronic diabetic foot ulcers" 23 : 31-38, 2014

38 Min Long, "An Essential Role of NRF2 in Diabetic Wound Healing" American Diabetes Association 65 (65): 780-793, 2016

39 SunilK Kota, "Aberrant angiogenesis: The gateway to diabetic complications" Medknow 16 (16): 918-, 2012

40 Barbara Ruszkowska-Ciastek, "A preliminary evaluation of VEGF-A, VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus" Zhejiang University Press 15 (15): 575-581, 2014